Chercheurs et industrie
Le principal obstacle à la rapidité et à la productivité de l'innovation dans le domaine des maladies rares est le coût et le manque d'accès fiable ou ouvert à des données complètes sur les patients.
This is because…
The data exists, but is captive within a silo, institutional or company-owned, because of institutional / technological constraints, or is being held for exclusive commercial purpose
The data may exist, but not in a useful form, where it is available, visible or useful to researchers or patient communities.
The data doesn’t yet exist (because patients can’t access genomic or other testing, there is not a way to effectively collect patient-reported information, etc.).
To address these needs and challenges RARE-X is building a platform that breaks down barriers to access ‘the right data’ while supporting the open sharing of this data at ‘the right time’, to accelerate advancements in rare disease understanding and therapy development. The RARE-X technology platform will include:
- Diagnostic Decision Support Engine for Clinicians + Whole Genome Sequencing where needed
- Data Collection Platform and Patient Data Portal Development – built to scale
- Data Use Oversight Technology
- Federated Data Sharing Technology
- Rare Disease Federated Data Library
The Technology Platform of RARE-X includes:
Federated Data Capabilities and a Rare Disease Federated Data Library
- Supporting an ecosystem of discovery
- Cross disease research
- Basket Trials
- Interconnecting disparate data
Data Collection Platform and portal development built to scale
- Developing Standardized/Common Data Modules (starting in Neuro)
- Ease of Use for patients
- Supporting – genotypic/phenotypic and other data (including other tech partners)
- Supporting Research-Ready (Fit-for-purpose) data collection
- Emphasis on strong governance and patient support